Try our Advanced Search for more refined results
Health - February, 2008
180 articles
- Teva Will Appeal Patent Ruling On P&G's Actonel
- Win For Federal Preemption And Device Makers
- Judge Chucks Securities Action Against Guidant
- MDL Panel Chooses Venue For Contrast Agent Suits
- Baxter Widens Recall As Blood-Thinner Deaths Mount
- Roche Enjoined In Patent Battle With Amgen
- Vytorin Class Actions Now Total 85: Merck
- Wyeth Faces Whistleblower Suits Over Prevnar
- Group Says Ruling Proves Thimerosal-Autism Link
- Health Net Subpoenaed By N.Y. Attorney General
- Pfizer Wins Dismissal Of Securities Suit Over Drug
- Bush Administration Won't Appeal Medicaid Order
- Ex-Exec Can Shield Info In Pfizer Whistleblower Spat
- Supplement Tycoon Ordered To Forfeit $33M
- Pregnancy Test Maker Awarded $14M In Patent Case
- Study Links Anemia Drugs To Increased Mortality Risk
- Dutch Court Invalidates Pfizer Lipitor Patent
- 6th Circuit Tosses MSP Suits, Threatens Sanctions
- Boston Scientific's Off-Label Stent Sales Probed
- Prosecution Can't Renege On Deal In Body Parts Case
- Federal Circuit Issues Mixed Ruling In Dako Case
- Third Wave, Qiagen Ready Appeals Over HPV Tests
- FDA To Bolster Post-Approval Drug Oversight
- Senate Probe Uncovers Widespread Doctor Payments
- Judge To Reconsider 2nd Claim In Stent Dispute
- India Considers Overriding Cancer Drug Patents
- Foley & Lardner May Add Defenses Over Patent Filing
- Sen. Grassley Seeks Info On Prodisc Researchers
- DLA Piper Snags Heller Ehrman Life Sciences Chair
- Judge Certifies Collective Action in Eli Lilly FLSA Suit
- Jury Finds Wyeth Culpable In Hormone Lawsuit
- AstraZeneca Gets Druggists' Antitrust Suit Tossed
- GSK Sues Barr Over Prostate Treatment Patents
- Bio-Imaging Rivals Lay Patent Claims To Rest
- Apotex, Pfizer Make Peace On Generic Neurontin
- Lilly Objects To Webcast Of Zyprexa Proceeding
- Medtronic Fined $10M For Attorneys' Misconduct
- DOJ Compels Divestiture in UnitedHealth Merger
- FDA Funding For Drug Ad Reviews Faces Debate
- 2 European Courts Reject Fosamax Patents
- WellPoint Hit With FLSA Suit By Salaried Nurses
- Under Pressure, Pfizer Pulls Jarvik's Lipitor Ads
- Genzyme Sues Over Synthetic Vitamin D Patents
- U.K.'s Direct To Pharmacy Model: Competition Risks
- High Court Will Not Hear St. Jude Valve Case
- Dechert Snags Partner From Ropes & Gray
- Fruit Products' Health Claims Squeeze Truth: FDA
- AstraZeneca To Appeal $215M Drug Pricing Verdict
- Justices' Diagnoses Vary in FDA Preemption Case
- Seizure Of Cosmetic Signals New Enforcement Trend
- FTC Continues Fight Against Reverse Payments
- L.A. City Attorney Sues Health Net Over Recission
- Prodisc Patient Widens Circle Of Blame
- High Court Won't Block Employer-Funded Health Care
- High Court Aims To Alter Product Liability Landscape
- FTC Frowns On Unions For Ohio Home Health Aides
- FDA Blocks Imports Of Some Cochlear Hearing Aids
- Kennedy, Waxman Vow To Intercept Medtronic Ruling
- Amgen Scoffs At Roche Proposal In EPO Patent Battle
- Louisiana Accuses Amgen Of Tying Cancer Drugs
- Tyco Unit Wins Jury Verdict In Patent Dispute
- Scope Of Riegel V. Medtronic Is Narrow: Experts
- Dutch Appellate Court Upholds Lipitor Patent
- Alpharma Loses Bid To Get State Wage Claims Tossed
- FDA Proposes Higher Animal Drug Review User Fees
- Lawmakers Demand Answers Over Heparin
- Trasylol Study Results Prove Damning For Bayer
- Smith & Nephew, Synthes Patent Case Settled
- CardioFocus Sues Rivals Over Laser Heart Device
- High Court Limits Device Liability With Medtronic
- Merck Appealing Canadian OK Of Vioxx Class Action
- Novartis Sues Bayer Over Hemophilia Drug Patent
- Judge Cuts $134M Verdict In Wyeth Hormone Trial
- Plaintiff Denied Class Status In Wyeth Hormone Suit
- Generic Version Of J&J Pain Patches Recalled
- Alexion To Pay $10M To Settle Patent Lawsuit
- Researcher Claims Bayer's Inaction Cost Lives
- Cephalon: FTC's Challenge To Patent Settlements
- Wyeth Wins Against $4M Race Discrimination Suit
- Wyeth Claims Victory In Thimerosal-Autism Case
- Glitch Left Chinese Heparin Plant Uninspected
- High Court Declines Appeal In Ear-Drop Patent Case
- FDA Pitches Off-Label Rules Amid Criticism
- Insurers Likely To Fight ERISA Discrimination Bill
- Judge Lets HHS Proceed With Bidding On Lab Tests
- Doctor Gets Another $69M From Boston Scientific
- The FCPA And The Health Care Industry
- Sanofi Targets Syringe Maker With Patent Suit
- Sanofi Accused Of Fraud In Clinical Trial Of Drug
- Heparin Problems Renew Questions Of Liability
- Plan Reduces Legal Risk For Drs. Who Report Errors
- Chinese Pharma Factory Not Inspected By FDA
- Novartis Hits Teva With Another Lotrel Suit
- FTC Says Cephalon Bought Off Would-Be Competitors
- Hologic Faces Another Suit Over Biopsy Devices
- Jury Exonerates Duane Morris Of Malpractice
- Smith & Nephew Salesman Excused From Liability Suit
- Caremark Settles Prescription Swap Claims For $14M
- J&J Recalls Pain Patches For Fatal Overdose Risk
- Legal Battle Brews Over SEC Stance On Proxy Access
- Abbott Must Face Overtime Claims In California
- Edwards' Valve Patent Dispute Crosses Atlantic
- Justices Asked To Block Employer-Funded Health Care
- Lamisil Poses Serious Health Risks: Report
- Study Says Bayer's Trasylol Safe For Some Patients
- Drugmakers Cleared Of Methamphetamine Liability
- Court Freezes Out Plaintiffs In P&G HeatWrap Suit
- N.Y. AG To Sue Health Care Cos. For Alleged Fraud
- Lilly Wins Bid To Shift Zyprexa Whistleblower Suit
- Amgen Probe Widens As Former Reps Take Action
- Lawyers Push For $45M Cut Of Guidant Settlement
- Lawmaker Calls For Leavitt To Be Punished
- Felons Endangering FDA Approvals: Republican Study
- Orion Files New Stalevo Suit After Sun Tweaks ANDA
- Boston Scientific Loses $432M Patent Case
- Lawmakers Keep Merck, Schering-Plough In Hot Seat
- Sanofi-Aventis Inks $500M Deal For Cancer Therapy
- Medtronic Ordered To Pay BrainLAB's Attorneys' Fees
- Wyeth Sues Apotex Over Injectable Protonix ANDA
- New Thai Government Reconsidering Patent Policy
- Michigan Sues Tyco, PwC Over Pension Funds
- Recent Pharmaceutical Cost Reimbursement Litigation
- SEC Nabs Trader Who Got Inside Tip On Chemed
- Medtronic Seeks Rehearing In Stent Patent Appeal
- Baxter Halts Production Of Multidose Heparin Vials
- Lumenis Settles Shareholder Class Action For $20M
- Vytorin Class Actions Pile Up Against Merck, Schering
- Ethicon Suffers Blow In Aortic Laceration Case
- Covidien Pays Medrad $17M, Ending Multiple Suits
- Wyeth Pressure May Have Led To FDA Vet Dismissal
- FDA Study Of Botox Safety Deepens Allergan's Frown
- Missouri Doctors Gain Right To Sue Hospitals
- Another Suit Over Schering's Clarinex Added To MDL
- Novartis Ordered To Pay $41M In Contact Lens Spat
- Jury Awards $31M In Hearing Aid Patent Case
- AstraZeneca Moves To Fend Off Generic Seroquel
- "Signature Disease" Status Doesn't Change Analysis
- Merck To Pay $650M To Settle Kickback, Pricing Suits
- Martek Biosciences Settles Securities Case For $6M
- Judge Lets $134M Prempro Verdict Stand
- End Of Fosamax Patent Heralds Payday For Generics
- Court Proposes Resolution To Bayer-Schering Dispute
- Part Of Synthes' Bone Plate Patent Invalid: Judge
- Novartis Unit To Appeal German Laxative Ban
- Lawmakers Probe Cos. Behind Lipitor-Touting Doc
- Deaths Prompt FDA Crackdown On Colchicine
- Agilent, Invitrogen End Lengthy Patent Battle
- FTC Seeks $256M In 2009 For Consumer Protection
- NRC Launches Probe Of Covidien Unit
- Inadvertent E-Mail Led To Scoop On Lilly Deal: Report
- Amgen Shareholder Anemia Drug Suit To Proceed
- Expansion Of The Family And Medical Leave Act
- Abbott Sues To Block Generic Depakote, Again
- Researchers, Investors In Prodisc Face Subpoenas
- Abbott Tells Relator To Back Up Antitrust Claims
- German Court Blocks Illegal Laxative Sales
- Trouble For Health Care Still Brews After Bly-McGee
- More Questions Raised Over Tamiflu
- Drug Study Finds Cypher, Taxus Stents Equally Safe
- Wisconsin's Fee Award In AWP Litigation Reversed
- Medical Device Co. Sued Over Valve Patent
- Paxil Antitrust Suit Bounces Back To State Court
- FDA Uneasy About Long-Form Zyprexa Side Effect
- Trainers Sue Physical Therapists, Claiming Monopoly
- Judge Throws Out J&J's Willful Infringement Claim
- White House Calls For FDA Budget Increase To $2.4B
- Novartis' Deal With Thais Averts License Battle
- Old Testimony Spurs New Claims In Amgen-Ariad Suit
- N.Y. Wants Drug-Pricing Data From AWP Defendants
- 9th Circ. Puts PeaceHealth Bundling Case On Hold
- Anti-Epilepsy Drugs Increase Suicide Risk: FDA
- Becton Dealt Another Setback In Antitrust MDL
- EU Again Takes Aim At German Pharmacy Law
- Generic Won't Infringe Crestor Patent, Apotex Claims
- Link Between Chantix, Psych Symptoms Likely: FDA
- Roche Loses Round In HIV Test Patent Case
- Judge Nixes Paxil Warning-Label Suit Against Glaxo
- Boehringer Sues Apotex To Protect Zantac Patent
- Merck May Face Criminal Probe On Vioxx: Report
- Biovail Faces Grand Jury Probe On Cardizem Launch